Initial experiences with methylhydrazine, a new cytotoxic agent

Backhouse, Tamara; Sicher, K.

doi:10.1016/s0009-9260(66)80073-9

Search citation statements

Order By: Relevance

Paper Sections

Select...

Other Antineoplastic Drugs1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1969

1983

Publication Types

Select...

Article3

Book3

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 8 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In vitro it combines with DNA (Bollag, 1965). It is an effective drug in the treatment of Hodgkin's disease, but it has little effect on solid tumours or in leukaemia (Martz, 1964;Kummer and Bucher, 1965;Scott, 1965;Backhouse and Sicher, 1966;De Vita et al, 1966;Fairley et al, 1966;Hansen et al, 1966).…”

Section: Other Antineoplastic Drugsmentioning

confidence: 99%

Cancer chemotherapy--the first twenty-five years.

Scott¹

1970

BMJ

View full text Add to dashboard Cite

Section: Other Antineoplastic Drugsmentioning

confidence: 99%

Cancer chemotherapy--the first twenty-five years.

Scott¹

1970

BMJ

View full text Add to dashboard Cite

Single-Agent Therapy for Hodgkin's Disease

Carter¹

1973

Arch Intern Med

View full text Add to dashboard Cite

We have reviewed existing data on single drugs in the chemotherapy of Hodgkin's disease in order to place in perspective the recent results with regimens employing combinations of drugs. Combination chemotherapy, by historical comparison with single-drug therapy, is clearly superior in the induction of complete remission of disease. However, many single agents, particularly those in the antimetabolite and antibiotic classes of antitumor drugs, have been evaluated only minimally and may yet play important roles in the design of future combination therapies. rapidity of effect, and his prejudice

show abstract

Chemotherapy of malignant melanoma

Luce

1972

Cancer

128

View full text Add to dashboard Cite

Initial experiences with methylhydrazine, a new cytotoxic agent

Cited by 8 publications

References 2 publications

Cancer chemotherapy--the first twenty-five years.

Cancer chemotherapy--the first twenty-five years.

Single-Agent Therapy for Hodgkin's Disease

Chemotherapy of malignant melanoma

Contact Info

Product

Resources

About